EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions

Yujun Hou, Xixia Chu, Jae-Hyeon Park, Qing Zhu, Mansoor Hussain, Zhiquan Li, Helena Borland Madsen, Beimeng Yang, Yong Wei, Yue Wang, Evandro F Fang, Deborah L Croteau und 1 weitere

Alzheimer's & Dementia · 2024-06 · 20 (6) · 4212-4233

DOI: 10.1002/alz.13847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 16.05.2024. Verfasst von Yujun Hou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Shanghai Key Laborator…. Hauptthemen laut MEDLINE: Alzheimer Disease, Coumarins, Lysosomes, Mice, Transgenic. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Natural Science Foundation of China, Lingang Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Compromised autophagy, including impaired mitophagy and lysosomal function, plays pivotal roles in Alzheimer's disease (AD). Urolithin A (UA) is a gut microbial metabolite of ellagic acid that stimulates mitophagy. The effects of UA's long‐term treatment of AD and mechanisms of action are unknown. METHODS We addressed these questions in three mouse models of AD with behavioral, electrophysiological, biochemical, and bioinformatic approaches. RESULTS Long‐term UA treatment significantly improved learning, memory, and olfactory function in different AD transgenic mice. UA also reduced amyloid beta (Aβ) and tau pathologies and enhanced long‐term potentiation. UA induced mitophagy via increasing lysosomal functions. UA improved cellular lysosomal function and normalized lysosomal cathepsins, primarily cathepsin Z, to restore lysosomal function in AD, indicating the critical role of cathepsins in UA‐induced therapeutic effects on AD. CONCLUSIONS Our study highlights the importance of lysosomal dysfunction in AD etiology and points to the high translational potential of UA. Highlights Long‐term urolithin A (UA) treatment improved learning, memory, and olfactory function in Alzheimer's disease (AD) mice. UA restored lysosomal functions in part by regulating cathepsin Z (Ctsz) protein. UA modulates immune responses and AD‐specific pathophysiological pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCoumarinsLysosomesMice, TransgenicDisease Models, AnimalMitophagyAnimalsMiceAmyloid beta-PeptidesCognition

Stichwörter der Autor:innen

Alzheimer's diseaseDNA repairautophagycathepsin Zlysosomemitophagyneuroinflammationurolithin A

Substanzen

Coumarins3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneAmyloid beta-Peptides

Autor:innen und Institutionen

  • Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem…
  • DNA Repair Section, National Institute on Aging, Baltimore, Maryland, USA.
  • Danish Center for Healthy Aging, ICMM, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
  • The Norwegian Centre on Healthy Ageing (NO-Age), Oslo, Akershus, Norway.
  • Computational Biology & Genomics Core, LGG, National Institute on Aging, Baltimore, Maryland, USA.

ORCID-Profile: Vilhelm A Bohr

Förderung

  • NIA NIH HHS
  • National Natural Science Foundation of China
  • Lingang Laboratory
  • Natural Science Foundation of Shanghai
  • Fundamental Research Funds for the Central Universities
  • HELSE SØR-ØST
  • Research Council of Norway
  • Akershus University Hospital

Zitieren

APA

Hou, Y., Chu, X., Park, J. H., Zhu, Q., Hussain, M., Li, Z., Madsen, H. B., Yang, B., Wei, Y., Wang, Y., Fang, E. F., Croteau, D. L., & Bohr, V. A. (2024). Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions. Alzheimer's & Dementia, 20(6), 4212-4233. https://doi.org/10.1002/alz.13847

Vancouver

Hou Y, Chu X, Park JH, Zhu Q, Hussain M, Li Z, et al. Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions. Alzheimer's & Dementia. 2024;20(6):4212-4233. doi:10.1002/alz.13847

BibTeX
@article{Hou2024,
  author = {Hou, Yujun and Chu, Xixia and Park, Jae-Hyeon and Zhu, Qing and Hussain, Mansoor and Li, Zhiquan and Madsen, Helena Borland and Yang, Beimeng and Wei, Yong and Wang, Yue and Fang, Evandro F and Croteau, Deborah L and Bohr, Vilhelm A},
  title = {Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {6},
  pages = {4212--4233},
  doi = {10.1002/alz.13847}
}
Kostenlos starten →